TWO · Healthcare

Anxo Pharmaceutical Co., Ltd. (6677)

Drug Manufacturers - Specialty & Generic

Anxo Pharmaceutical Co., Ltd. (6677) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6677

P/E ratio

18.00

Anxo Pharmaceutical Co., Ltd. (6677) — FAQ

What is 6677's P/E ratio?

The price-to-earnings (P/E) ratio for Anxo Pharmaceutical Co., Ltd. (6677) is 18.00 (data as of 2026-03-23).

Does Anxo Pharmaceutical Co., Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Anxo Pharmaceutical Co., Ltd. (6677). Check the MyAverix Finance app for the latest dividend data.

What sector is Anxo Pharmaceutical Co., Ltd. in?

Anxo Pharmaceutical Co., Ltd. (6677) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 6677 listed on?

6677 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)